For over ten years we have worked on operations that others cannot anticipate. M&A, internationalisation, value creation — under unified direction with a top-tier advisor network.
For over ten years we have worked on complex operations: acquisitions, turnarounds, international markets, sustainable governance. We do not sell slides. We produce measurable results.
Our advantage is not size. It is the speed with which we see where the market is heading — and the ability to move there first.
"When an idea makes the headlines, for us it is already history. We find it ten years earlier."— Celebron Team
Three active mandates — due diligence in progress
Five active clients — ongoing advisory
Three RECs being structured — public admin & healthcare
Pre-positioning — awaiting Official Gazette
Africa corridor — Asia operations — two deals
Two turnaround mandates in execution
We support management teams and investors at every stage of the investment cycle. From opportunity identification to post-deal value creation, with integrated risk vision.
Learn more →We identify growth opportunities, optimise pricing strategies and structure transformation paths across multiple economic cycles. From diagnosis to operational execution.
Learn more →International network of direct relationships and joint ventures with global advisory platforms. Europe, Asia, Africa — with local presence and geopolitical vision on complex scenarios.
Learn more →The first Energy Accounts are closing. Billions of panels reaching end-of-life by 2030. Silicon, silver, copper to recover. An industrial market to be structured. Celebron is already positioned.
Approfondisci →Decree Law 30 April 2026. 160,000 housing units, €18–25bn market. Celebron operates as advisory and orchestrator from Q1 2026.
RECs move from experimental project to structured financial asset. Those already inside will have a decisive competitive advantage.
From 2026, large companies must certify supplier sustainability. ESG advisory becomes infrastructure, not optional.
MDR regulation opens the medical AI market. Connected devices with certified AI become the new standard in healthcare facilities.
Healthcare RECs, storage, AI consumption optimisation. Hospital facilities will move from cost centres to production nodes. ESG + healthcare + REC convergence.
European pressure on traceability and sustainability transforms sub-Saharan Africa into a strategic partner. Those present today will have dominant positions tomorrow.
Behaviour, context, predictive AI will replace faces and fingerprints. A multi-billion market to be restructured in the next five years.
Between demographic ageing, NRRP funds and regional health authority tenders, home telecare becomes national healthcare infrastructure. A structural market to be built — Celebron is positioned.
Celebron has been active on the Housing Plan since Q1 2026. Structures, deals and partners already in place.
When an idea makes the headlines, for us it is already history. We find it ten years earlier.
DORMIA is a sleep monitoring system that integrates AI and IoT to detect neurophysiological patterns through the mattress. Born as a consumer product, it grows towards MDR certification for the National Health Service.
Research explores the connection between a sensor-equipped mattress and new digital medical systems: a scalable platform where AI transforms biometric data into personalised care protocols.
The mattress detects neurophysiological activity patterns during sleep. AI algorithms identify correlations between sleep quality and health parameters. Research ongoing with clinical partners.
MDR certification pathway for integration into healthcare facilities. Interface with digital medical records and NHS telemedicine systems.
AI models trained on over 46 million biometric samples. The system learns individual patterns and improves over time. Clinical scalability tested on 300+ facilities.
Dual consumer + medical track. Modular architecture designed for integration into NHS contracts, anti-decubitus tenders and home telecare programmes. The model is replicable at national and international scale, with export potential into foreign healthcare markets with high technology content.
If you are looking for a partner to navigate a complex decision — an acquisition, a new market, a transformation — write to us. We respond within 48 hours.